Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

CME gets approval for new European derivatives exchange

Wednesday, March 12, 2014

Benedicte Gravrand, Opalesque Geneva:

CME Group, a large Chicago-based derivatives marketplace, has just received approval from the UK’s Financial Conduct Authority (FCA) for a London-based derivatives exchange. It will be called CME Europe Ltd and will launch on 27th April.

According to the announcement, the exchange has received approval to list its first commodity products, and as previously announced, plans to launch a full suite of FX futures products on the same date, subject to final regulatory approval of certain operational clearing conditions. The initial commodity products to be listed on the exchange include biodiesel, which were previously cleared as swaps on CME Clearing Europe. The latter will provide clearing services to the new exchange.

CME started its foray in Europe a while back, and this year, the group started its new European Trade Repository.

"We have made a commitment to expand our business in London and in Europe and have done that over the last 30 years since establishing our office in London in 1979," Lee Betsill, CEO of ......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1